Johnston: Early-stage cancer detection in dogs through a blood-based screening test
Why dogs often hide cancer until late stages, and what a blood test may catch before symptoms appear.
Episode aired Feb 21, 2026·Page synthesised May 31, 2026·Last reviewed May 31, 2026
What this episode covers
- Cancer in dogs grows much faster than in humans, so by the time clinical signs appear, the cancer is often already advanced.
- A new peptide-array blood test may detect tumor signals before symptoms appear, using antibody patterns specific to abnormal cell signaling.
- The same approach may eventually support a low-cost preventive vaccine across many cancer types, though both diagnostic and vaccine remain at early commercial stages.
Why it matters
If early-stage detection meaningfully improves canine cancer outcomes, then choices around routine bloodwork, wellness exams, breed risk, and treatment timing all start to look different. It touches your dog's screening schedule, your vet conversations, and how you read symptoms across joints, organs, and behavior.
What stands out
- Most people think wellness exams catch cancer early, but only about 4 percent of dog cancer diagnoses come from wellness visits; roughly 88 percent follow an owner noticing a symptom (developer-reported survey data).
- Most people think Stage 1 versus Stage 2 is a small difference, but in dogs the two-year survival gap is dramatic for several cancers because tumors grow much faster than in people (published comparative oncology studies).
- Most people assume DNA-based liquid biopsies pick up early cancer well, but in published data they detect only a small share of Stage 1 tumors (existing liquid-biopsy literature).
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
Do a hands-on lump and lymph node check at home monthly, and note any new lump, persistent limp, or appetite change for two weeks in a simple journal.
Where to start
Small low-friction starters covering the main moves from this episode.
- Learn the common cancers in your dog's breed and what early signs look like.
- Run a hands-on home check for lumps and skin changes once a month.
- Notice if your dog hesitates on stairs, limps briefly, or seems unusually tired.
- Keep wellness exams at least once a year, twice for senior or high-risk dogs.
- Track your dog's weight and appetite over time; sudden changes are worth flagging.
- If a screening test is offered, ask your vet what a positive result would actually change in your dog's care.
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Discuss with your vet whether a blood-based early-detection test fits your dog's breed, age, and risk profile before agreeing to it.Moderate evidence
- Book a full wellness visit every 6 to 12 months from age 5 onward, and ask your vet to log lumps, weight trend, and energy level at each visit.Moderate evidence
- Schedule a yearly cancer-focused conversation with your vet from age 5 onward, covering breed risk, lump checks, baseline bloodwork, and whether newer screening tests are appropriate.Limited evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my dog's breed, age, and family history, would a blood-based early-detection cancer test meaningfully change what we do next, or mainly provide curiosity-level information?
- Given my dog's current health and any medications, is more frequent wellness bloodwork worth scheduling, or would the same money be better spent on imaging if a symptom appears?
- Given a hypothetical positive screening result, what would the next confirmatory steps actually look like in your clinic before we made any treatment decision?
Full doctor prep with ranked questions available in the full topic page
Context
Translational researcher and inventor focused on early-stage cancer detection in dogs through a peptide-array blood test that reads antibody patterns linked to tumor signaling. Strongest on the dog-cancer early-detection problem and on building affordable diagnostics; less certain on whether his preventive cancer vaccine framing translates into population-level outcomes, and his role as founder of Calvary (the company commercializing the test) means his performance numbers should be read alongside independent veterinary replication as it appears.
This is not settled science yet. The strongest performance data on the blood-based early-detection test comes from the company developing it, with independent veterinary replication still limited. The speaker founded and leads Calvary, the company commercializing this test; this does not invalidate the content but is worth knowing when evaluating recommendations. This does not mean you should change or stop your current veterinary care on your own.
Where people go wrong
- Acting on a single positive screening result without a confirmatory diagnosis such as imaging or biopsy.Owners may agree to surgery, chemotherapy, or expensive follow-up that the result alone does not justify, with real cost and stress to the dog.
- Treating a normal wellness exam as enough to rule out cancer in an older or higher-risk dog.Cancers may grow silently between visits and be caught only at Stage 2 or later, when cure rates drop sharply.
What to expect over time
- Years 1 to 4 of your dog's lifeCancer risk is generally low; focus is on routine wellness, dental care, weight, and learning what normal looks like for your dog.
- Age 5 onwardCancer risk rises with age and varies by breed; vet visits may shift to twice a year, with closer attention to lumps, weight, and behavior changes.
- Senior yearsScreening conversations become more nuanced; treatment decisions balance survival benefit, quality of life, and what the dog can tolerate, alongside owner values.